Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells
- 11 December 2004
- journal article
- research article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 54 (8) , 781-791
Abstract
Background: CXCR4, the chemokine receptor for CXCL12, has recently been involved in the metastatic process of several neoplasms. Materials and methods: The expression of CXCR4 was evaluated by immunohistochemistry of colorectal tissue samples and by flow cytometry on Caco2, GEO, SW480, SW48, Lovo and SW620 human colon carcinoma cell lines. Correlations with pathological characteristics of the specimens were analysed with chi-square test. To verify the functional status of CXCR4, cell lines were tested in adhesion, migration, and proliferation assays. Results: We studied the expression of CXCR4 in 88 human colorectal tissues and we found that CXCR4 was expressed in >10% of epithelial cells in 50% of normal mucosae (7/14), in 55% of polyps (29/53), in all of carcinomas (16/16) and hepatic metastasis (5/5). Notably, CXCR4 was significantly over-expressed in cancerous lesions (carcinomas and metastasis) compared to non-cancerous lesions (normal mucosa and polyps) (P=0.003) and in adenomatous polyps versus hyperplastic polyps (P=0.009). The diameter of a polyp was also significantly associated with CXCR4 expression (P=0.031). SW480, SW48 and SW620 cell lines showed the highest levels of CXCR4 (60–80% of positive cells). Adhesion, migration, and proliferation increased in response to the CXCL12 chemokine. These effects were abrogated by the addition of anti-CXCR4 antibodies. Further, CXCL12 activated ERK1/2 in SW480 cells. Conclusions: These data suggest that CXCR4 might play a role in colon cancer cell properties and that anti-CXCR4 antibodies could have therapeutic effects against colorectal cancer.Keywords
This publication has 22 references indexed in Scilit:
- Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHLNature, 2003
- CXC Chemokine Receptor 4 Expression and Function in Human Anaplastic Thyroid Cancer CellsThe Journal of Clinical Endocrinology & Metabolism, 2003
- CXCR4–SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesionBlood, 2002
- CXCR4/CXCL12 expression and signalling in kidney cancerBritish Journal of Cancer, 2002
- Expression of Functional Chemokine Receptors CXCR3 and CXCR4 on Human Melanoma CellsJournal of Biological Chemistry, 2001
- Chemokines and the Molecular Basis of Cancer MetastasisNew England Journal of Medicine, 2001
- Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumoursBritish Journal of Cancer, 2001
- Chemokine Regulation of Normal and Pathologic Immune ResponsesStem Cells, 2001
- Involvement of chemokine receptors in breast cancer metastasisNature, 2001
- Stromal cells in lymph nodes attractB‐lymphoma cells via production ofstromal cell‐derived factor‐1European Journal of Haematology, 2000